The SmartHeart monitoring system from Israel’s SHL Telemedicine (see here previously) is undergoing trials at Imperial College London. It has reduced ER visits by 27.5% and hospital readmission rates by 55%, surpassing expectations. https://www.shl-telemedicine.com/wp-content/uploads/2023/09/20230926_Mayo-Imperial-initial-results-Final.pdf

Israel’s SHL Telemedicine specializes in providing remote diagnosis and monitoring services for patients suffering from chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD). Its second German acquisition in two years is GPH, which monitors 10,000 heart patients. http://www.globes.co.il/en/article-shl-telemedicine-buys-german-co-gph-1001021356